| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―May―28 |
Inhibitory effects and structural analysis of drug candidate PF-07817883 against coronaviral main proteases (Mpro) and SARS-CoV-2 Mpro mutants |
Zhenyu Zhao, Xuelan Zhou, Haihai Jiang, Weiwei Wang, Bing Fan, Jian Li |
| 2 |
[GO] |
2026―Jan―06 |
Structural insights of the coronavirus main protease in complex with the non-covalent inhibitor CCF0058981 |
Pei Zeng, Xuelan Zhou, Li Guo, Wenwen Li, Jian Li |
| 3 |
[GO] |
2025―Feb―12 |
Production and cryo-electron microscopy structure of an internally tagged SARS-CoV-2 spike ecto-domain construct |
Suruchi Singh, Yi Liu, Meghan Burke, Vamseedhar Rayaprolu, Stephen E. Stein, S. Saif Hasan |
| 4 |
[GO] |
2024―Jul―29 |
Structure of SARS-CoV-2 MTase nsp14 with the inhibitor STM957 reveals inhibition mechanism that is shared with a poxviral MTase VP39 |
Eva Zilecka, Martin Klima, Milan Stefek, Milan Dejmek, Radim Nencka, Evzen Boura |
| 5 |
[GO] |
2020―Oct―05 |
Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein |
Thomas Lemmin, David Kalbermatter, Daniel Harder, Philippe Plattet, Dimitrios Fotiadis |
|
